Re-examining the Entry-to-Practice PharmD Experiment.


Journal

American journal of pharmaceutical education
ISSN: 1553-6467
Titre abrégé: Am J Pharm Educ
Pays: United States
ID NLM: 0372650

Informations de publication

Date de publication:
05 2023
Historique:
received: 05 07 2022
accepted: 01 08 2022
medline: 9 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Since 2000, the Doctor of Pharmacy degree has served as the entry-level credential for pharmacy practice in the United States, Some 20-plus years following the complete transition to an entry-level clinical doctorate in pharmacy, a re-examination of the outcomes of this move and the trajectory of the profession is merited. Particular attention might be given to the increasing diversity within pharmacy and the myriad of practice types. Regardless of the path forward, intentional and critical appraisals of both the pros and cons of the entry-level Doctor of Pharmacy, as well as the future of pharmacy practice, are warranted. Nursing is a case study in contrast to pharmacy, with its multiple degree and training programs and its hierarchical and graded system of practice. Nursing practice clearly links progressive levels of education to increasing clinical privileges.

Identifiants

pubmed: 37288674
pii: S0002-9459(23)00002-5
doi: 10.1016/j.ajpe.2022.08.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100016

Informations de copyright

Copyright © 2023 American Association of Colleges of Pharmacy. Published by Elsevier Inc. All rights reserved.

Auteurs

Frank Romanelli (F)

University of Kentucky College of Pharmacy, Lexington, KY, USA. Electronic address: Froma2@uky.edu.

Daniel Malcom (D)

Sullivan University College of Pharmacy and Health Sciences, Louisville, KY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH